Wells Fargo & Company Biogen Inc. Transaction History

Wells Fargo & Company

$433 Billion
Q4 2024

A detailed history of Wells Fargo & Company transactions in Biogen Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 111,043 shares of BIIB stock, worth $15.5 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

111,043

Previous 206,470 46.22%

Holding current value

$15.5 Million

Previous $40 Million 57.57%

% of portfolio

0.0%

Previous 0.01%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 12, 2025	SELL	$146.47 - $191.55 $14 Million - $18.3 Million	-95,427 Reduced 46.22%	111,043 $17 Million
Q3 2024 Nov 13, 2024	SELL	$189.07 - $236.8 $7.81 Million - $9.78 Million	-41,290 Reduced 16.67%	206,470 $40 Million
Q2 2024 Aug 13, 2024	BUY	$190.52 - $236.72 $5.08 Million - $6.32 Million	26,684 Added 12.07%	247,760 $57.4 Million
Q1 2024 May 10, 2024	SELL	$212.02 - $267.71 $2.2 Million - $2.78 Million	-10,375 Reduced 4.48%	221,076 $47.7 Million
Q4 2023 Feb 09, 2024	BUY	$222.59 - $267.94 $3.73 Million - $4.5 Million	16,778 Added 7.82%	231,451 $59.9 Million
Q3 2023 Nov 13, 2023	SELL	$253.3 - $285.89 $8.9 Million - $10.1 Million	-35,155 Reduced 14.07%	214,673 $55.2 Million
Q2 2023 Aug 15, 2023	SELL	$275.25 - $318.06 $1.43 Million - $1.65 Million	-5,194 Reduced 2.04%	249,828 $71.2 Million
Q1 2023 May 12, 2023	SELL	$256.56 - $292.34 $2.84 Million - $3.24 Million	-11,086 Reduced 4.17%	255,022 $70.9 Million
Q4 2022 Feb 13, 2023	SELL	$252.44 - $306.72 $13.3 Million - $16.2 Million	-52,870 Reduced 16.57%	266,108 $73.7 Million
Q3 2022 Nov 14, 2022	SELL	$194.69 - $268.46 $7.81 Million - $10.8 Million	-40,101 Reduced 11.17%	318,978 $85.2 Million
Q2 2022 Aug 12, 2022	SELL	$187.54 - $223.02 $15.1 Million - $18 Million	-80,651 Reduced 18.34%	359,079 $73.2 Million
Q1 2022 May 16, 2022	BUY	$193.77 - $244.14 $7.51 Million - $9.46 Million	38,751 Added 9.66%	439,730 $92.6 Million
Q4 2021 Feb 14, 2022	SELL	$223.92 - $287.77 $38.6 Million - $49.7 Million	-172,597 Reduced 30.09%	400,979 $96.2 Million
Q3 2021 Nov 15, 2021	BUY	$282.99 - $369.05 $6.77 Million - $8.84 Million	23,940 Added 4.36%	573,576 $162 Million
Q2 2021 Aug 16, 2021	SELL	$259.0 - $414.71 $8.05 Million - $12.9 Million	-31,100 Reduced 5.36%	549,636 $190 Million
Q1 2021 May 13, 2021	SELL	$242.95 - $284.63 $4.36 Million - $5.11 Million	-17,943 Reduced 3.0%	580,736 $162 Million
Q4 2020 Feb 09, 2021	SELL	$236.26 - $355.63 $36.3 Million - $54.7 Million	-153,694 Reduced 20.43%	598,679 $147 Million
Q3 2020 Nov 05, 2020	BUY	$264.77 - $305.71 $2.03 Million - $2.34 Million	7,649 Added 1.03%	752,373 $213 Million
Q2 2020 Aug 13, 2020	BUY	$258.66 - $342.55 $10.9 Million - $14.5 Million	42,187 Added 6.0%	744,724 $199 Million
Q1 2020 May 14, 2020	BUY	$268.85 - $341.04 $189 Million - $240 Million	702,537 New	702,537 $222 Million

Others Institutions Holding BIIB

# of Institutions

1,006

Shares Held

126M

Call Options Held

1.77M

Put Options Held

2.34M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $20B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Biogen Inc. Transaction History